202 related articles for article (PubMed ID: 24755817)
1. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
[TBL] [Abstract][Full Text] [Related]
2. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
3. [A case of pneumatosis intestinalis associated with sunitinib treatment for renal cell carcinoma].
Choi YA; Sim EH; Lee KE; Ko SY; Seo MJ; Yang YJ; Park JC; Park SY
Korean J Gastroenterol; 2013 Jun; 61(6):347-50. PubMed ID: 23877217
[TBL] [Abstract][Full Text] [Related]
4. Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.
Lee YS; Han JJ; Kim SY; Maeng CH
BMC Cancer; 2017 Nov; 17(1):732. PubMed ID: 29121860
[TBL] [Abstract][Full Text] [Related]
5. Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor.
Jarkowski A; Hare R; Francescutti V; Wilkinson N; Khushalani N
Anticancer Res; 2011 Oct; 31(10):3429-32. PubMed ID: 21965757
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.
Zhao J; Zhu Y; Zhang C; Wang X; He H; Wang H; Wu Y; Zhou W; Shen Z
Urol Oncol; 2013 Nov; 31(8):1800-5. PubMed ID: 22658883
[TBL] [Abstract][Full Text] [Related]
7. [A case of interstitial lung disease due to sunitinib].
Sekiguchi Z; Takizawa A; Takeshima T; Tsuchiya F; Iwasaki A; Matsuyama S; Hirooka N
Hinyokika Kiyo; 2012 Sep; 58(9):481-5. PubMed ID: 23070386
[TBL] [Abstract][Full Text] [Related]
8. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib.
Gomez-Abuin G; Karam AA; Mezzadri NA; Bas CA
Clin Genitourin Cancer; 2009 Jan; 7(1):62-3. PubMed ID: 19213671
[TBL] [Abstract][Full Text] [Related]
9. [Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].
Okazaki S; Hori J; Watanabe M; Hashizume K; Kobayashi S; Azumi M; Kita M; Iwata T; Matsumoto S; Kakizaki H
Hinyokika Kiyo; 2016 Feb; 62(2):73-6. PubMed ID: 27018409
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
Kushima H; Ishii H; Kadota J
Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
[TBL] [Abstract][Full Text] [Related]
12. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
[TBL] [Abstract][Full Text] [Related]
13. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
14. [A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].
Tatenuma T; Yao M; Sakata R; Sano F; Makiyama K; Nakaigawa N; Nakayama T; Inayama Y; Kubota Y
Hinyokika Kiyo; 2013 Feb; 59(2):97-101. PubMed ID: 23552751
[TBL] [Abstract][Full Text] [Related]
15. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
Yoshinaga A; Kamata S
Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
[TBL] [Abstract][Full Text] [Related]
17. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
19. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
Wang C; Takeda K; Shiba M; Takayama H; Munakata S
Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug].
Kobayashi H; Ashikari A; Namitome R; Yagi Y; Kohno Y; Nishiyama T; Saito S
Nihon Hinyokika Gakkai Zasshi; 2012 Sep; 103(5):660-4. PubMed ID: 23342925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]